Title | Synaptic vesicle-omics in mice captures signatures of aging and synucleinopathy. |
Publication Type | Journal Article |
Year of Publication | 2025 |
Authors | Gao V, Chlebowicz J, Gaskin K, Briano JA, Komer LE, Pineda A, Jhalani S, Ahmad S, Uwaifo E, Black LS, Haller JE, Przedborski S, Lane DA, Zhang S, Sharma M, Burré J |
Journal | Nat Commun |
Volume | 16 |
Issue | 1 |
Pagination | 4079 |
Date Published | 2025 May 01 |
ISSN | 2041-1723 |
Keywords | Aging, alpha-Synuclein, Animals, Female, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Parkinson Disease, Synaptic Vesicles, Synucleinopathies |
Abstract | Neurotransmitter release occurs through exocytosis of synaptic vesicles. α-Synuclein's function and dysfunction in Parkinson's disease and other synucleinopathies is thought to be tightly linked to synaptic vesicle binding. Age is the biggest risk factor for synucleinopathy, and ~15% of synaptic vesicle proteins have been linked to central nervous system diseases. Yet, age- and disease-induced changes in synaptic vesicles remain unexplored. Via systematic analysis of synaptic vesicles at the ultrastructural, protein, and lipid levels, we reveal specific changes in synaptic vesicle populations, proteins, and lipids over age in wild-type mice and in α-synuclein knockout mice with and without expression of human α-synuclein. Strikingly, we find several previously undescribed synaptic changes in mice lacking α-synuclein, suggesting that loss of α-synuclein function contributes to synaptic dysfunction. These findings not only provide insights into synaptic vesicle biology and disease mechanisms in synucleinopathy, but also serve as a baseline for further mechanistic exploration of age- and disease-related alterations in synaptic vesicles. |
DOI | 10.1038/s41467-025-59441-7 |
Alternate Journal | Nat Commun |
PubMed ID | 40312501 |
PubMed Central ID | PMC12046008 |
Grant List | R01NS126342 / / U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) / 1R25GM152362 / / U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) / R01 NS121077 / NS / NINDS NIH HHS / United States OT2 OD030544 / OD / NIH HHS / United States R01 AG052505 / AG / NIA NIH HHS / United States R21AG085144 / / U.S. Department of Health & Human Services | NIH | National Institute on Aging (U.S. National Institute on Aging) / R01 AG083949 / AG / NIA NIH HHS / United States R21NS127939 / / U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) / R21 NS127939 / NS / NINDS NIH HHS / United States F31 NS125949 / NS / NINDS NIH HHS / United States R25 GM152362 / GM / NIGMS NIH HHS / United States R01NS095988 / / U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) / UG3MH129381 / / U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) / R01NS113960 / / U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) / R21 AG085144 / AG / NIA NIH HHS / United States R01NS136423 / / U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) / RF1 NS126342 / NS / NINDS NIH HHS / United States F31NS125949 / / U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) / R01 NS113960 / NS / NINDS NIH HHS / United States R01NS113960-02S1 / / U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) / R01 NS136423 / NS / NINDS NIH HHS / United States UG3 MH129381 / MH / NIMH NIH HHS / United States R01NS121077 / / U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NINDS) / R01 NS095988 / NS / NINDS NIH HHS / United States U2C DK119886 / DK / NIDDK NIH HHS / United States |